IVRSX
Price
$27.44
Change
+$0.05 (+0.18%)
Updated
Jul 21 closing price
Net Assets
149.8M
VRTPX
Price
$21.71
Change
+$0.07 (+0.32%)
Updated
Jul 21 closing price
Net Assets
9.48B
Interact to see
Advertisement

IVRSX vs VRTPX

Header iconIVRSX vs VRTPX Comparison
Open Charts IVRSX vs VRTPXBanner chart's image
VY® CBRE Real Estate S
Price$27.44
Change+$0.05 (+0.18%)
VolumeN/A
Net Assets149.8M
Vanguard Real Estate II Index
Price$21.71
Change+$0.07 (+0.32%)
VolumeN/A
Net Assets9.48B
IVRSX vs VRTPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IVRSX vs. VRTPX commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVRSX is a Buy and VRTPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VRTPX has more cash in the bank: 9.48B vs. IVRSX (150M). VRTPX pays higher dividends than IVRSX: VRTPX (3.80) vs IVRSX (2.54). IVRSX was incepted earlier than VRTPX: IVRSX (37 years) vs VRTPX (8 years). IVRSX (1.26) is less costly to investors than VRTPX (0.08). IVRSX is a more actively managed with annual turnover of: 82.00 vs. VRTPX (4.00). IVRSX has a lower initial minimum investment than VRTPX: IVRSX (0) vs VRTPX (100000000). VRTPX annual gain was more profitable for investors over the last year : 5.27 vs. IVRSX (-0.33). VRTPX return over 5 years is better than : 37.03 vs. IVRSX (10.72).
IVRSXVRTPXIVRSX / VRTPX
Total Expense Ratio1.000.081,250%
Annual Report Gross Expense Ratio1.260.081,575%
Fund Existence37 years8 years-
Gain YTD-1.4463.001-48%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets150M9.48B2%
Annual Yield % from dividends2.543.8067%
Returns for 1 year-0.335.27-6%
Returns for 3 years-0.147.62-2%
Returns for 5 years10.7237.0329%
Returns for 10 years0.89N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NQCAX5.37N/A
N/A
Nuveen Large Cap Value Opportunities A
FCCGX24.99N/A
N/A
Fidelity Advisor Small Cap Growth C
DEQAX14.16N/A
N/A
BNY Mellon Global Equity Income - A
FJACX11.19N/A
N/A
Fidelity Series Small Cap Discovery
BGLUX45.26N/A
N/A
Baron Global Advantage R6